Cargando…
Complete Remission of Severe Eosinophilic Otitis Media With Dupilumab: A Case Report
Eosinophilic otitis media (EOM) is a difficult‐to‐treat otitis media (OM) characterized by eosinophilic accumulation in the middle ear mucosa and secretion. Associated sensorineural hearing loss can eventually lead to (functional) deafness. EOM is strongly associated with type 2 inflammation driven...
Autores principales: | van der Lans, Rik J. L., van Spronsen, Erik, Fokkens, Wytske J., Reitsma, Sietze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292739/ https://www.ncbi.nlm.nih.gov/pubmed/34216146 http://dx.doi.org/10.1002/lary.29730 |
Ejemplares similares
-
Therapeutic Options for Chronic Rhinosinusitis in N-ERD Patients
por: van der Lans, Rik J. L., et al.
Publicado: (2021) -
Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds
por: Chuang, Chien‐Chia, et al.
Publicado: (2021) -
Real‐life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps
por: van der Lans, Rik Johannes Leonardus, et al.
Publicado: (2021) -
Fungal extracts detected in eosinophilic chronic rhinosinusitis induced cytokines from the nasal polyp cells
por: Hirotsu, Mikio, et al.
Publicado: (2014) -
The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan
por: Fujieda, Shigeharu, et al.
Publicado: (2020)